Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
<Evidence xmlns="http://hl7.org/fhir">
<id value="379742"/>
<meta>
<versionId value="5"/>
<lastUpdated value="2025-07-01T19:02:55.589Z"/>
</meta>
<text>
<status value="empty"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>[No data.]</p></div>
</text>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status">
<valueCodeableConcept>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/cited-artifact-status-type"/>
<code value="active"/>
<display value="Active"/>
</coding>
</valueCodeableConcept>
</extension>
<url value="https://fevir.net/resources/Evidence/379742"/>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net/FOI"/>
<value value="379742"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<name
value="Evidence_for_Results_for_Adverse_event_free_and_hypertension_control_at_12_weeks_in_QUARTET_USA_Trial_Quadpill_group"/>
<title
value="Evidence for Results for Adverse event free and hypertension control at 12 weeks in QUARTET USA Trial Quadpill group"/>
<citeAs
value="Evidence for Results for Adverse event free and hypertension control at 12 weeks in QUARTET USA Trial Quadpill group [Database Entry: FHIR Evidence Resource]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 379742. Revised 2025-07-01. Available at: https://fevir.net/resources/Evidence/379742. Computable resource at: https://fevir.net/resources/Evidence/379742#json."/>
<status value="active"/>
<author>
<name value="Joanne Dehnbostel"/>
</author>
<publisher value="Computable Publishing LLC"/>
<contact>
<telecom>
<system value="email"/>
<value value="support@computablepublishing.com"/>
</telecom>
</contact>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
<relatesTo>
<type value="part-of"/>
<targetReference>🔗
<reference value="Composition/375280"/>
<type value="Composition"/>
<display value="Outcome Measure Report for QUARTET USA Trial"/>
</targetReference>
</relatesTo>
<description
value="This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide."/>
<variableDefinition>
<variableRole value="population"/>
<observed>🔗
<reference value="Group/375175"/>
<type value="Group"/>
<display value="QUARTET USA Trial Quadpill group"/>
</observed>
</variableDefinition>
<variableDefinition>
<variableRole value="outcome"/>
<observed>🔗
<reference value="EvidenceVariable/375278"/>
<type value="EvidenceVariable"/>
<display
value="Adverse event free and hypertension control at 12 weeks"/>
</observed>
</variableDefinition>
<statistic>
<note>
<text
value="The reported percentage (17.2%) does not match the value reported for this outcome in ClinicalTrials.gov results reporting (20% at https://fevir.net/resources/Composition/370504)"/>
</note>
<statisticType>
<coding>
<system value="https://fevir.net/sevco"/>
<code value="STATO:0000639"/>
<display value="percentage"/>
</coding>
</statisticType>
<quantity>
<value value="17.24137931034483"/>
<unit value="%"/>
<system value="http://unitsofmeasure.org"/>
<code value="%"/>
</quantity>
<numberAffected value="5"/>
<sampleSize>
<extension
url="http://hl7.org/fhir/uv/ebm/StructureDefinition/number-analyzed">
<valueUnsignedInt value="29"/>
</extension>
<numberOfParticipants value="32"/>
<knownDataCount value="29"/>
</sampleSize>
</statistic>
</Evidence>